2020 inventory: The top ten most influential figures in the domestic medical and medical circles

2020 is a special year.
year, the domestic economy quickly resumed production under the shroud of the epidemic.
2020 is a year of deep health reform.
under the pressure of volume procurement, consistent evaluation and anti-corruption upgrading of medical reform, China's biopharmaceutical industry has entered a year of transformation, gradually changing from a large generic drug country to a large country of innovative drugs.
, these 10 heavyweight pharmaceutical and medical industry, or in the fight against the new crown epidemic, or from their respective fields, to reshape the domestic biopharmaceutical industry pattern, the construction of a new industrial system ... To promote the development of the domestic pharmaceutical and medical sectors, has made indelible achievements.
rankings are in no order.
1, the Chinese people are unique - Zhong Nanshan Zhong Nanshan, a member of the Chinese Academy of Engineering, "The Order of the Republic" recipient.
2003, Zhong Nanshan made outstanding contributions to SARS prevention and control.
said, "Bring the heaviest patients to me."
In this year's fight against the new crown epidemic, he was 84 years old at risk, as the National Health And Wellness Commission's high-level expert group leader, the joint research team system carried out a series of Chinese medicine anti-new coronavirus in-body drug effectiveness screening.
Zhong Nanshan academician put his fate and the land of Huaxia, and in the dark to fight the fate of the Chinese people closely linked together! The Chinese are unique, pay tribute to Zhong Lao! 2, the annual scientific research bull - Shi One Gong Shi, a member of the Chinese Academy of Sciences, the co-founder of No cheng Jianhua, the president of West Lake University.
one of the most high-profile IPOs in the pharmaceutical industry in 2020 is the listing of biopharmaceutical company Novarma.
company was founded by Dr. Cui Yusong, a member of the Chinese Academy of Sciences and president of West Lake University, and Dr. Cui Yusong, an expert on national talent projects.
, the Chinese Academy of Sciences announced the winners of the 2020 Chen Jiaxuan Science Prize and the Chen Jiaxuan Youth Science Award.
, Shi Igong, a member of the Chinese Academy of Sciences, won the Life Sciences Prize with a prize of 1 million yuan for his research project "Research on the Structure and Molecular Structure of The Shear body".
December, Shi Yigong as co-founder of The first anti-cancer drug, the class 1 innovative drug Auboutini tablets (trade name: Inocy) was approved for treatment: (1) adult adult set cell lymphoma (MCL) patients who have received at least one treatment in the past.
(2) patients with chronic lymphoblastic leukemia (CLL)/small lymphocytic lymphoma (SLL) who have received at least one treatment in the past.
return home to start a business 4 years to create an IPO, scientific research, career is not wrong, Shi One Gong is worthy of the annual medical research bull.
3, the annual "health care dark horse - Zhong , Chairman of Wantay Biopharmaceity, Chairman of Health Hall Co., Ltd., founder of Farmer Shanquan.
, his Company's Wante Biopharmace companies sounded the bell, rising 1440 per cent to a market capitalisation of $84.2bn.
September, farmer Shanquan, known as "Water Maotai", was officially listed on the Hong Kong Stock Exchange, with its founder, Chung , holding HK$447.8bn in market capitalisation of the two companies, making Mr Ma and Mr Ma China's new richest man.
November, the 2020 Forbes China Rich List was released, and Zhong , the head of the healthcare company, was ranked third in China with 359.65 billion yuan.
zhongleft-handed vaccine, right-handed health care products, soft drinks, on the throne of China's richest man.
deserved to be named "Health Care Dark Horse of the Year."
4, the hero of the towel - Li Lanxuan Li Lanxuan, a member of the Chinese Academy of Engineering, is currently the director of the National Key Laboratory for the Diagnosis and Treatment of Infectious Diseases.
the new crown outbreak, Li Lanxuan went deep into the scene of the epidemic prevention and control, and studied the problem of epidemic prevention and control and diagnosis and treatment.
in determining the phenomenon of "people-to-people", Li Lanxuan academician and other experts reported to superiors, Wuhan must immediately seal the city, timely block the rapid spread of the epidemic to the country.
after screening for a variety of antiviral drugs, Li Lanjun's team found that abidol and dalunavir, two drugs, were effective in suppressing coronaviruses.
From rushing to Wuhan to studying the pneumonia vaccine, from the proposal to seal the city to the anger rumors, the 70-year-old grandmother showed us what is a towel style, what is a great doctor.
she devoted her scalding life to the cause of medicine and to her family' national conditions.
5, the annual "pharmaceutical stocks big winner" - Zhang Lei, founder and CHIEF executive officer of Gao Wei Capital, director of the Sino-US Exchange Foundation.
March, Zhang Lei led Gao's capital and Chen'an Foundation to invest 1,242 million yuan and 828 million yuan, respectively, and was assigned a 9% and 6% stake in Hualan Biomass Vaccine Co., Ltd., a subsidiary of Hualan Biomass.
August, it continued to reduce its holdings of JD.com's high-stakes capital, turning around with the money it earned but investing in JD.com Health, the world's youngest unicorn, for $5.8 billion.
, Zhang Lei sold again, 1 billion buy medicine bull shares Kailaiying, the current high capital has floated 20%, almost 200 million.
has been called the godfather of contemporary Chinese "value investment" by the media.
successfully introduced Yale's investment philosophy into China, but also developed an investment model more suitable for China.
said that China's biopharmaceutical industry is entering the stage of innovation 2.0, he will be firmly optimistic about the pharmaceutical industry.
6, the annual "Academic Entrepreneurial Giant" - Xie Xiaoliang Xie Xiaoliang, biophysical chemist, member of the National Academy of Sciences, member of the National Academy of Medicine, member of the American Academy of Arts and Sciences, foreign academician of the Chinese Academy of Sciences.
In June this year, Xie Xiaoliang founded Beijing Danshuo Biopharmaceutical Co., Ltd., and three months later, Danshu Biopharmaceutical completed nearly 100 million yuan of RMB A financing, which will be used to upgrade single-cell sequencing technology, promote clinical development of anti-neocytovirus and antibodies at full speed, and expand its product pipeline portfolio.
scientific research fruitful, the establishment of the company in three months to obtain hundreds of millions of financing, "four academicians" Xie Xiaoliang worthy of the "nearest Chinese to the Nobel Prize", is a well-deserved annual "academic entrepreneurs."
7, anti-epidemic hero - Zhang Yongzhen Zhang Yongzhen, Shanghai Public Health Clinical Center, Fudan University School of Life Sciences Professor.
the beginning of this year's outbreak, Professor Zhang Yongzhen made a 40-hour effort to bring the genetic map of the new coronavirus to the fore.
his research results laid the foundation for rapid identification of new coronavirus, rapid screening of antiviral drugs and rapid development of new coronary vaccines, and made outstanding contributions to the global war against disease.
8, the annual "vaccine pioneer" - Liu Jingxuan Liu Jingxuan, chairman of the National Pharmaceutical Group, party secretary.
Since the outbreak of the new crown, Liu Jingxuan led 150,000 national drug users to do a good job in war-time state of emergency allocation of medical supplies, drug vaccine research and development and production, as well as medical treatment and other work, in the epidemic can be diagnosed, treatable, preventable and other fields to create a number of world first.
Not only that, the National Pharmaceutical Group has undertaken all provinces and cities in the country, especially Hubei Province and Wuhan City, more than 70% of the emergency supplies supply tasks, and achieved nucleic acid molecular testing kits, plasma treatment for the recovered, specific immunoglobulin, new corona inactivated vaccine and other "eight global first" major achievements, creating 98 days of research and development of new crown vaccine, 60 days to build a high-grade biosecurity workshop miracle.
, the new crown inactivated vaccine of Chinese medicine leads the world in clinical trials, large-scale production, emergency use and so on, and is leading the way in safety and effectiveness.
9, the annual "Queen of Uric acid" - Zhao Yan Zhao Yan, chairman of Huaxi Bio.
, China is currently the world's largest producer and marketer of hyalurinoic acid, and Zhao Yan's Huaxi Biotech Co., Ltd. is the world's largest supplier of hyalurotic acid raw materials.
as the head of Huaxi bio, Zhao Yan by the "face value economy" wind, vigorously develop the hyalurinoic acid industry chain.
2020, Huaxi Bio has developed a series of soft tissue filler products based on cross-link technology platform.
, three products have passed the NMPA approval, access to three types of medical device registration certificate (registration number: National Arms Note 20203130295, National Arms Note 20203130568, National Arms Note 20203130569), and constantly break the monopoly of foreign brands on domestic hyaluric acid products.
and Zhao Yan also by virtue of the market share of uric acid and ahead of the investment vision, by the media called "the queen of boric acid."
10, the "breathing machine king" of the year -- Li Xiting Li Xiting, chairman of Mei Rui Medical.
, the spread of the global new crown epidemic is continuing to catalyz the rapid development of the medical device industry and reconstruct the new industrial pattern.
This round of the epidemic, not only fully open the domestic replacement space for medical devices, even in the global emergency also opened China's high-end medical manufacturing comprehensive export road, but also promote domestic medical device brands to further the international stage - and into the international competition sequence with major brands.
Medical is one of the biggest beneficiaries of the new medical device landscape, with shares soaring more than 100 per cent from their pre-Spring Festival lows and a market capitalisation of more than 200bn yuan.
As the largest medical device manufacturer in China, The growth rate of Meirui medical performance has been at a new high, and the production capacity of monitors, ventilators and other equipment has been expanded sixfold, making an important contribution to the global war against disease, while Li Xiting's title of "King of Respirators" has also spread in the industry.